
Katie Porter: Taking Big Business to Task While Running for Dianne Feinstein’s Seat
On with Kara Swisher
00:00
Corporate Accountability and Public Trust
This chapter critiques Big Pharma's priorities, focusing on excessive executive pay and stock buybacks at the expense of essential research for life-saving drugs. It highlights the challenges of regulating corporate practices and the need for accountability in both the pharmaceutical industry and Congress, emphasizing the importance of restoring public trust in government actions.
Transcript
Play full episode